Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer
Authors
Keywords
miR-141-3p, EMT, Bone metastasis, NF-κB signaling and prostate cancer
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 36, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-04
DOI
10.1186/s13046-017-0645-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway
- (2017) Dong Ren et al. Molecular Cancer
- Phospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca2+-permeable Cationic Channel in lung carcinoma cells
- (2017) Xin Zhang et al. Molecular Cancer
- Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway
- (2017) Dong Ren et al. Oncotarget
- Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway
- (2016) Guohua Lou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells
- (2015) MIN WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma
- (2015) Shuiying Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells
- (2015) Riesa M. Burnett et al. Oncotarget
- Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells
- (2014) Dong Ren et al. CELL AND TISSUE RESEARCH
- miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression
- (2014) X. Chen et al. CLINICAL CANCER RESEARCH
- Loss of miR-100 enhances migration, invasion, epithelialmesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2
- (2014) MIN WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway
- (2014) M K Siu et al. ONCOGENE
- Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer
- (2013) Daniel P. Nguyen et al. BJU INTERNATIONAL
- CCN3 promotes prostate cancer bone metastasis by modulating the tumor–bone microenvironment through RANKL-dependent pathway
- (2013) Po-Chun Chen et al. CARCINOGENESIS
- Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR-145
- (2013) DONG REN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145
- (2013) Wei Guo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines
- (2013) Yao-Hui Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines
- (2013) Masanobu Tsubaki et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The complexity of NF-κB signaling in inflammation and cancer
- (2013) Bastian Hoesel et al. Molecular Cancer
- miRNA-141, Downregulated in Pancreatic Cancer, Inhibits Cell Proliferation and Invasion by Directly Targeting MAP4K4
- (2013) Gang Zhao et al. MOLECULAR CANCER THERAPEUTICS
- TRAF2 is an NF-κB-activating oncogene in epithelial cancers
- (2013) R R Shen et al. ONCOGENE
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
- (2012) D. Madhavan et al. CLINICAL CANCER RESEARCH
- Ubiquitination in signaling to and activation of IKK
- (2012) Zhijian J. Chen IMMUNOLOGICAL REVIEWS
- Effect of Ulinastatin and Taxotere on growth inhibition, apoptosis of breast carcinoma cells is related to a decrease in signal conduction of JNk-2 and NF-kappaB
- (2012) Hong Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms
- (2012) Y-N Liu et al. ONCOGENE
- TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer
- (2011) Daniel T. Starczynowski et al. JOURNAL OF CLINICAL INVESTIGATION
- NF-kappaB in Lung Tumorigenesis
- (2011) Zhenjian Cai et al. Cancers
- microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network
- (2010) Liming Zhang et al. CARCINOGENESIS
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets
- (2009) Raffaele Baffa et al. JOURNAL OF PATHOLOGY
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
- Shared Principles in NF-κB Signaling
- (2008) Matthew S. Hayden et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started